Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Hisamitsu discloses new cyclooxygenase inhibitor

April 26, 1996

Nihon Iyakuhin's NSAID research bears fruit

April 26, 1996

Dihydrofolate reductase inhibitors synthesized at Duquesne University

April 26, 1996

FD-501: SS Pharm.'s newest fluoroquinolone

April 26, 1996

Purpuromycin derivative MDL-63604 shows potential for vaginal infections

April 26, 1996

NPC-18688 displays long-lasting antihyperalgesic effects in rodents

April 26, 1996

OT-7100, Otsuka's new analgesic for peripheral pain

April 26, 1996

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...